Glenmark Pharma
BSE: 532296 | NSE: GLENMARK | ISIN: INE935A01035 | Pharmaceuticals
| Balance Sheet |
------------------- in Rs. Cr. ------------------- |
|
Mar '04 |
Mar '05 |
Mar '06 |
Mar '07 |
Mar '08 |
 |
|
12 mths |
12 mths |
12 mths |
12 mths |
12 mths |
 |
| Sources Of Funds |
|
|
|
|
| Total Share Capital |
21.85 |
43.72 |
43.74 |
24.01 |
24.87 |
| Equity Share Capital |
11.85 |
23.72 |
23.74 |
24.01 |
24.87 |
| Share Application Money |
0.01 |
0.00 |
0.00 |
0.00 |
0.00 |
| Preference Share Capital |
10.00 |
20.00 |
20.00 |
0.00 |
0.00 |
| Reserves |
213.21 |
242.98 |
275.01 |
426.15 |
1,003.38 |
| Revaluation Reserves |
0.00 |
0.00 |
0.00 |
0.00 |
0.00 |
| Networth |
235.07 |
286.70 |
318.75 |
450.16 |
1,028.25 |
| Secured Loans |
102.94 |
129.30 |
141.83 |
170.03 |
191.33 |
| Unsecured Loans |
11.56 |
307.43 |
586.21 |
737.45 |
333.22 |
| Total Debt |
114.50 |
436.73 |
728.04 |
907.48 |
524.55 |
| Total Liabilities |
349.57 |
723.43 |
1,046.79 |
1,357.64 |
1,552.80 |
|
Mar '04 |
Mar '05 |
Mar '06 |
Mar '07 |
Mar '08 |
 |
|
12 mths |
12 mths |
12 mths |
12 mths |
12 mths |
 |
| Application Of Funds |
|
|
|
|
| Gross Block |
172.35 |
258.62 |
318.96 |
364.66 |
483.74 |
| Less: Accum. Depreciation |
34.69 |
49.32 |
66.40 |
87.74 |
116.20 |
| Net Block |
137.66 |
209.30 |
252.56 |
276.92 |
367.54 |
| Capital Work in Progress |
24.50 |
12.91 |
57.56 |
156.30 |
225.57 |
| Investments |
29.96 |
26.46 |
43.56 |
139.10 |
196.70 |
| Inventories |
82.16 |
111.06 |
138.89 |
218.20 |
273.63 |
| Sundry Debtors |
130.48 |
182.10 |
282.79 |
420.99 |
595.16 |
| Cash and Bank Balance |
6.77 |
109.28 |
4.20 |
8.21 |
7.73 |
| Total Current Assets |
219.41 |
402.44 |
425.88 |
647.40 |
876.52 |
| Loans and Advances |
41.59 |
189.72 |
343.40 |
402.31 |
265.59 |
| Fixed Deposits |
0.00 |
0.00 |
84.96 |
3.18 |
3.44 |
| Total CA, Loans & Advances |
261.00 |
592.16 |
854.24 |
1,052.89 |
1,145.55 |
| Deffered Credit |
0.00 |
0.00 |
0.00 |
0.00 |
0.00 |
| Current Liabilities |
91.40 |
107.67 |
160.32 |
266.88 |
376.96 |
| Provisions |
12.80 |
9.71 |
0.81 |
0.67 |
5.61 |
| Total CL & Provisions |
104.20 |
117.38 |
161.13 |
267.55 |
382.57 |
| Net Current Assets |
156.80 |
474.78 |
693.11 |
785.34 |
762.98 |
| Miscellaneous Expenses |
0.64 |
0.00 |
0.00 |
0.00 |
0.00 |
| Total Assets |
349.56 |
723.45 |
1,046.79 |
1,357.66 |
1,552.79 |
 |
| Contingent Liabilities |
5.11 |
0.46 |
4.82 |
131.23 |
587.54 |
| Book Value (Rs) |
37.99 |
22.48 |
25.16 |
37.50 |
41.34 |
|
 |
| Source : Asian CERC |
 |